RetinalGenix Technologies Inc.
RTGN
$3.20
-$0.35-9.86%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.34M | 2.52M | 2.51M | 2.46M | 3.94M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.42M | 2.67M | 2.74M | 2.76M | 4.32M |
| Operating Income | -2.42M | -2.67M | -2.74M | -2.76M | -4.32M |
| Income Before Tax | -2.43M | -2.67M | -2.75M | -2.76M | -4.32M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.43 | -2.67 | -2.75 | -2.76 | -4.32 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.43M | -2.67M | -2.75M | -2.76M | -4.32M |
| EBIT | -2.42M | -2.67M | -2.74M | -2.76M | -4.32M |
| EBITDA | -2.42M | -2.67M | -2.74M | -2.76M | -4.32M |
| EPS Basic | -0.13 | -0.15 | -0.15 | -0.15 | -0.24 |
| Normalized Basic EPS | -0.08 | -0.09 | -0.09 | -0.10 | -0.15 |
| EPS Diluted | -0.13 | -0.15 | -0.15 | -0.15 | -0.24 |
| Normalized Diluted EPS | -0.08 | -0.09 | -0.09 | -0.10 | -0.15 |
| Average Basic Shares Outstanding | 74.07M | 73.58M | 72.97M | 72.50M | 71.65M |
| Average Diluted Shares Outstanding | 74.07M | 73.58M | 72.97M | 72.50M | 71.65M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |